ラブ29に依存するレシピキナーゼ2の非対称活性化
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
PubMedで要約を見る
まとめ
この要約は機械生成です。レウシンに富んだリピートキナーゼ2 (LRRK2) の機能獲得変異がパーキンソン病を引き起こす. 新しい構造は,Rab29がLRRK2を活性化する方法を示し,パーキンソン病の治療のためにLRRK2阻害剤を開発するための洞察を提供します.
科学分野
- 神経科学
- 構造生物学
- 遺伝学
背景
- レウシンに富んだリピートキナーゼ2 (LRRK2) の機能獲得変異は,遅発のパーキンソン病の最も一般的な遺伝的原因です.
- LRRK2の活性化は空間的に調節され,Rab GTPaseであるRab29によって膜臓器細胞に誘導される.
研究 の 目的
- Rab29によるLRRK2活性化の構造的メカニズムを解明する.
- パーキンソン病に対するLRRK2阻害剤の設計に関する洞察を提供するためです.
主な方法
- Rab29- LRRK2複合体の構造を決定するために,冷凍電子顕微鏡 (cryo- EM) が使用されました.
- LRRK2の募集と活性化中に捕捉された3つの異なる小分子状態の分析.
主要な成果
- Rab29は2つの活性の中央プロトマーと2つの非活性周辺プロトマーからなるLRRK2の新型テトラメリックアセンブリを誘導する.
- テトラメアの活性LRRK2プロトメアは,DNL201のようなタイプIキナーゼ阻害剤が標的とする形状に似ている.
結論
- この研究は,Rab29によるLRRK2の空間調節の構造的基礎を明らかにしている.
- これらの発見は,パーキンソン病の治療のためのLRRK2阻害剤の合理的な設計のための重要な洞察を提供します.
関連する概念動画
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Guanine nucleotide exchange factors or GEF,
GTPase-activating proteins or GAPs, and
Guanine nucleotide-dissociation inhibitors or GDIs.
The GEF activates the GTPase by exchanging the bound-GDP with GTP. The...